Saladaga, Baby Girl .

HRN: 28-71-28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
AMPICILLIN 250MG (VIAL)
03/19/2026
03/26/2026
IV
140mg
Q12
T/c Neonatal Sepsis
Remove - Pending Acceptance
03/19/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/19/2026
03/26/2026
IV
45mg
Q24
T/C Neonatal Sepsis
Remove - Pending Acceptance
03/22/2026
MUPIROCIN 2%, 15G (TUBE)
03/22/2026
03/29/2026
TOPICAL
As Needed
BID
Phlebitis
Remove - Pending Acceptance
03/25/2026
CEFTAZIDIME 1GM (VIAL)
03/25/2026
03/31/2026
IV
115mg
Q6
Neonatal Sepsis
Checking Initial Appropriateness 
03/28/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/28/2026
04/03/2026
IV
12mg
Q6
Neonatal Sepsis
Remove - Pending Acceptance
03/28/2026
FLUCONAZOLE 150MG (CAP)
03/28/2026
04/03/2026
PO
28mg Then 14mg
Q24
Neonatal Sepsis
Remove - Pending Acceptance
03/28/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/28/2026
04/03/2026
IV
28mg Then 14mg
OD
Neonatal Sepsis
Remove - Pending Acceptance
03/30/2026
CLINDAMYCIN 300MG (CAP)
03/30/2026
04/05/2026
PO
12mg
Q8
Neonatal Sepsis
Remove - Pending Acceptance
04/05/2026
CLINDAMYCIN 300MG (CAP)
04/05/2026
04/09/2026
ORAL
12mg Pptab
Q8
Neonatal Sepsis; Neonatal Pneumonia
Remove - Pending Acceptance
04/07/2026
FLUCONAZOLE 50MG (CAP)
04/07/2026
04/07/2026
PO
28mg
Loading Dose
Neonatal Sepsis
Checking Initial Appropriateness 
04/07/2026
FLUCONAZOLE 50MG (CAP)
04/07/2026
04/14/2026
PO
14mg
Q24h
Neonatal Sepsis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: